Maintenance therapy with trofosfamide, idarubicin and etoposide in patients with rhabdomyosarcoma and other high-risk soft tissue sarcomas (CWS-2007-HR): a multicentre, open-label, randomised controlled phase 3 trial.

Koscielniak E, Ljungman G, Kazanowska B, Niggli F, Sparber-Sauer M, Handgretinger R, Zimmermann M, Boos J, Blank B, Hallmen E, Teichert von Lüttichau I, Schmid I, Fröhlich B, Müller HL, Behnisch W, Ladenstein R, Scheer M, Vokuhl C, von Kalle T, Blattmann C, Bielack S, Klingebiel T

Open source

DOI: 10.1016/j.eclinm.2024.102957
Published: 2024 Dec
Container: EClinicalMedicine
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.eclinm.2024.102957,
  title = {Maintenance therapy with trofosfamide, idarubicin and etoposide in patients with rhabdomyosarcoma and other high-risk soft tissue sarcomas (CWS-2007-HR): a multicentre, open-label, randomised controlled phase 3 trial.},
  author = {Koscielniak E and Ljungman G and Kazanowska B and Niggli F and Sparber-Sauer M and Handgretinger R and Zimmermann M and Boos J and Blank B and Hallmen E and Teichert von Lüttichau I and Schmid I and Fröhlich B and Müller HL and Behnisch W and Ladenstein R and Scheer M and Vokuhl C and von Kalle T and Blattmann C and Bielack S and Klingebiel T},
  year = {2024},
  journal = {EClinicalMedicine},
  doi = {10.1016/j.eclinm.2024.102957},
  url = {https://doi.org/10.1016/j.eclinm.2024.102957}
}

RIS

TY  - JOUR
TI  - Maintenance therapy with trofosfamide, idarubicin and etoposide in patients with rhabdomyosarcoma and other high-risk soft tissue sarcomas (CWS-2007-HR): a multicentre, open-label, randomised controlled phase 3 trial.
AU  - Koscielniak E
AU  - Ljungman G
AU  - Kazanowska B
AU  - Niggli F
AU  - Sparber-Sauer M
AU  - Handgretinger R
AU  - Zimmermann M
AU  - Boos J
AU  - Blank B
AU  - Hallmen E
AU  - Teichert von Lüttichau I
AU  - Schmid I
AU  - Fröhlich B
AU  - Müller HL
AU  - Behnisch W
AU  - Ladenstein R
AU  - Scheer M
AU  - Vokuhl C
AU  - von Kalle T
AU  - Blattmann C
AU  - Bielack S
AU  - Klingebiel T
PY  - 2024
JO  - EClinicalMedicine
DO  - 10.1016/j.eclinm.2024.102957
UR  - https://doi.org/10.1016/j.eclinm.2024.102957
ER  -

APA

E, K., G, L., B, K., F, N., M, S., R, H., M, Z., J, B., B, B., E, H., I, T. V. L., I, S., B, F., HL, M., W, B., R, L., M, S., C, V., T, V. K., C, B., S, B., & T, K. (2024). Maintenance therapy with trofosfamide, idarubicin and etoposide in patients with rhabdomyosarcoma and other high-risk soft tissue sarcomas (CWS-2007-HR): a multicentre, open-label, randomised controlled phase 3 trial.. EClinicalMedicine. https://doi.org/10.1016/j.eclinm.2024.102957

Source records

pubmed · retrieved 2026-09-25T10:58:20.314Z